TCTR20210902006已完成不适用
Alterations in F-18 fluorodeoxyglucose PET/MRI and O-15 water PET brain findings in patients with neurological symptoms after COVID-19 vaccination: A pilot study
ational Cyclotron and PET Centre0 个研究点目标入组 8 人开始时间: 2021年9月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- N/A (No limit) 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •neurological symptoms after the first COVID-19 vaccination underwent CT, MRI, F-18 FDG PET/MRI and O-15 water PET of the brain. After 7 days, each patient underwent a follow-up F-18 FDG PET/MRI and O-15 water PET of the brain.
排除标准
- 未提供
研究者
相似试验
撤回
早期 1 期
A Study of 1 8F-FDHT PET/MRIScans in Women With Breast CancerBreast CancerBreast CarcinomaMetastatic Breast CarcinomaFemale Breast CancerMetastatic Breast CancerNCT06145399Memorial Sloan Kettering Cancer Center
招募中
不适用
Deuterium Metabolic MRI and [18F]-flourodesoxyglucose Positron Emission Tomography for Assessment of Treatment Response Following Radioembolization of Liver Metastasis; pilot study,cancerNL-OMON56433niversitair Medisch Centrum Utrecht15
招募中
不适用
Changes in 18F-NaF PET/CT and 18F-FDG PET/CT after 223Ra Dichloride Treatment in Patients With Locally Recurrent of Metastatic OsteosarcomaKCT0002905Korea Cancer Center Hospital20
招募中
不适用
Changes in 18F-NaF PET/CT and 18F-FDG PET/CT after 223Ra Dichloride Treatment in Patients With Castration-Resistant Prostate Cancer with Osseous MetastasesKCT0002899Korea Cancer Center Hospital20
招募中
不适用
Changes in 18F-NaF PET/CT and 18F-FDG PET/CT after 223Ra Dichloride Treatment in Patients with Breast Cancer with Osseous MetastasesKCT0002909Korea Cancer Center Hospital20